PRGX GLOBAL, INC. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - August 9, 2011

Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R3.htm
10-Q - FORM 10-Q - PRGX GLOBAL, INC.g25303e10vq.htm
EX-31.1 - EX-31.1 - PRGX GLOBAL, INC.g25303exv31w1.htm
EX-10.1 - EX-10.1 - PRGX GLOBAL, INC.g25303exv10w1.htm
EX-31.2 - EX-31.2 - PRGX GLOBAL, INC.g25303exv31w2.htm
EX-32.1 - EX-32.1 - PRGX GLOBAL, INC.g25303exv32w1.htm
EXCEL - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R6.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R2.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R7.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R4.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R8.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R9.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R1.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R13.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R12.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R14.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R11.htm
XML - IDEA: XBRL DOCUMENT - PRGX GLOBAL, INC.R10.htm
People who read this document also read:
Document
CORCEPT THERAPEUTICS INC - 10-Q, Quarterly Report
v2.3.0.11
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands
 6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net earnings (loss) $ 1,082 $ (3,400)
Adjustments to reconcile net earnings (loss) from operations to net cash provided by (used in) operating activities:    
Depreciation and amortization 4,645 4,312
Amortization of deferred loan costs (Note G) 91 1,451
Stock-based compensation expense 2,202 1,876
Loss on sale of property and equipment 2 2
Deferred income taxes (269) (540)
Foreign currency transaction (gains) losses on intercompany balances (879) 1,712
Changes in assets and liabilities:    
Restricted cash (3) 86
Billed receivables 488 1,951
Unbilled receivables (2,226) 495
Prepaid expenses and other current assets (1,807) (641)
Other assets (52) 20
Accounts payable and accrued expenses 2,525 (3,060)
Accrued payroll and related expenses 4,806 (3,258)
Refund liabilities (161) (331)
Deferred revenue (322) 267
Noncurrent compensation obligations 170 (855)
Other long-term liabilities (109) (421)
Net cash provided by (used in) operating activities 10,183 (334)
Cash flows from investing activities:    
Business acquisition   (3,059)
Purchases of property and equipment, net of disposal proceeds (4,227) (3,978)
Net cash used in investing activities (4,227) (7,037)
Cash flows from financing activities:    
Repayment of former credit facility (Note G)   (14,070)
Repayments of long-term debt and capital lease obligations (1,500) (1,671)
Proceeds from term loan (Note G)   15,000
Restricted stock remitted by employees for taxes (994) (201)
Proceeds from option exercises 308  
Payments for deferred loan costs   (619)
Payments of deferred acquisition consideration   (782)
Net cash used in financing activities (2,186) (2,343)
Effect of exchange rates on cash and cash equivalents 686 (1,003)
Net change in cash and cash equivalents 4,456 (10,717)
Cash and cash equivalents at beginning of period 18,448 33,026
Cash and cash equivalents at end of period 22,904 22,309
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest 221 380
Cash paid during the period for income taxes, net of refunds received $ 1,924 $ 942

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA


This web site and associated pages are not associated with, endorsed by, or sponsored by PRGX GLOBAL, INC. and has no official or unofficial affiliation with PRGX GLOBAL, INC.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.